Literature DB >> 26026935

Comparison of epitheliotrophic factors in autologous serum eyedrops from sera of chronic renal failure patients vs. normal controls.

Na Hee Kang1, Shina Lee2, Roo Min Jun3,4.   

Abstract

PURPOSE: To investigate the composition and biological activity of serum epitheliotrophic factors from chronic renal failure (CRF) patients vs. healthy controls.
METHODS: Twenty, 50 and 100 % autologous serum eyedrops (ASEs) were prepared from 16 CRF patients and 16 normal subjects. Serum epithelial growth factor (EGF), platelet-derived growth factor-AB (PDGF-AB), transforming growth factor-β1 (TGF-β1) and fibronectin levels were quantified using enzyme-linked immunosorbent assay kits. A 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazoliumbromide (MTT) assay was used to compare the proliferative effects of serum from CRF patients and healthy donors in a human corneal epithelial cell (HCEC) culture model. Migration assays were conducted via manual scraping of HCECs for migratory potential of ASEs. Morphologic changes were studied with transmission electron microscopy (TEM).
RESULTS: EGF, PDGF-AB and TGF-β1 levels in ASEs from healthy donors were significantly higher than in serum of CRF patients. Cellular proliferation was similar in the CRF patient and normal control groups. ASEs from the normal group had a significantly higher effect on cell migration. ASEs in both groups facilitated better proliferation and migration than the negative control. Furthermore, we observed an enhancement after incubation with diluted serum vs. undiluted serum. In TEM analysis, HCECs incubated with CRF patients' 50 % ASEs showed some loss of microvilli without alterations of cytoplasmic organelles.
CONCLUSIONS: Epitheliotrophic factors concentrations and biologic activities from CRF patient sera differed from healthy controls. ASEs in CRF patients are also helpful in the corneal healing process, especially when applied at a 50 % concentration.

Entities:  

Keywords:  Autologous serum eyedrops; Chronic renal failure; Epitheliotrophic factors; Human corneal epithelial cell

Mesh:

Substances:

Year:  2015        PMID: 26026935     DOI: 10.1007/s00417-015-3056-5

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  28 in total

1.  Serum growth factors in hemodialyzed patients.

Authors:  Leszek Paczek; Małgorzata Gomółka; Stanisław Niemczyk; Irena Bartłomiejczyk; Dorota Gerwatowska; Katerina Sebekova; August Heidland
Journal:  Artif Organs       Date:  2004-03       Impact factor: 3.094

2.  Effect of hemodialysis (HD) on intraocular pressure, ocular surface, and macular change in patients with chronic renal failure. Effect of hemodialysis on the ophthalmologic findings.

Authors:  Ji Won Jung; Myung Hun Yoon; Seoung Woo Lee; Hee Seung Chin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-03       Impact factor: 3.117

3.  Corneal wound healing promoted by 3 blood derivatives: an in vitro and in vivo comparative study.

Authors:  Vanesa Freire; Noelia Andollo; Jaime Etxebarria; Raquel Hernáez-Moya; Juan A Durán; María-Celia Morales
Journal:  Cornea       Date:  2014-06       Impact factor: 2.651

Review 4.  Ocular problems in the patient with end-stage renal disease.

Authors:  Gaia Mullaem; Mitchell H Rosner
Journal:  Semin Dial       Date:  2012-06-11       Impact factor: 3.455

Review 5.  Autologous serum eye drops for ocular surface disorders.

Authors:  G Geerling; S Maclennan; D Hartwig
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

6.  Autologous serum eye drops for the treatment of dry eye diseases.

Authors:  Takashi Kojima; Akihiro Higuchi; Eiki Goto; Yukihiro Matsumoto; Murat Dogru; Kazuo Tsubota
Journal:  Cornea       Date:  2008-09       Impact factor: 2.651

7.  [Epitheliotrophic capacity of serum eye drops from healthy donors versus serum from immunosuppressed patients with rheumatoid arthritis].

Authors:  S Harloff; D Hartwig; K Kasper; T Wedel; M Müller; G Geerling
Journal:  Klin Monbl Augenheilkd       Date:  2008-03       Impact factor: 0.700

8.  Increased salivary concentration of human epidermal growth factor in patients undergoing CAPD.

Authors:  S Dagogo-Jack; R S Rodger; P Kendall-Taylor
Journal:  Perit Dial Int       Date:  1991       Impact factor: 1.756

9.  Stability of serum eye drops after storage of 6 months.

Authors:  Kai R Fischer; Andreas Opitz; Markus Böeck; Gerd Geerling
Journal:  Cornea       Date:  2012-11       Impact factor: 2.651

10.  Alterations in ocular surface and corneal thickness in relation to metabolic control in patients with chronic renal failure.

Authors:  Zeynep Aktaş; Sengül Ozdek; Umut Asli Dinç; Nalan Akyürek; Veli Atalay; Galip Güz; Berati Hasanreisoglu
Journal:  Nephrology (Carlton)       Date:  2007-08       Impact factor: 2.506

View more
  1 in total

Review 1.  Blood-Based Treatments for Severe Dry Eye Disease: The Need of a Consensus.

Authors:  Federico Bernabei; Matilde Roda; Marina Buzzi; Marco Pellegrini; Giuseppe Giannaccare; Piera Versura
Journal:  J Clin Med       Date:  2019-09-17       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.